Psylutions and the DEA Milestone: A New Chapter for Regulated Psilocybin Therapies
Psylutions celebrates a historic milestone as the DEA advances psilocybin toward rescheduling. The move signals a shift from stigma to science, paving the way for research, patient access, and regulated therapies with safety and precision at the core.

